Brevinin-1ITa

General Information


DRACP ID  DRACP00753

Peptide Name   Brevinin-1ITa

Sequence  IVPFLLGMVPKLVCLITKKC

Sequence Length  20

UniProt ID  C0HL47 

PubChem CID  Not available

Origin  skin secretions of the Italian stream frog Rana italica (Ranidae)

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MDA-MB-231 Breast adenocarcinoma Carcinoma LC50=8 μM CellTiter-Glo Lumines- cent Cell Viability assay 24h 1
A549 Lung adenocarcinoma Carcinoma LC50=18 μM CellTiter-Glo Lumines- cent Cell Viability assay 24h 1
HT-29 Colon adenocarcinoma Carcinoma LC50=18 μM CellTiter-Glo Lumines- cent Cell Viability assay 24h 1

Hemolytic Activity  mouse erythrocytes: LC50=7 μM

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00753

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C105H183N23O22S3

Absent amino acids  ADEHNQRSWY

Common amino acids  L

Mass  255503

Pl  9.67

Basic residues  3

Acidic residues  0

Hydrophobic residues  10

Net charge  3

Boman Index  3125

Hydrophobicity  152.5

Aliphatic Index  160.5

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  125

Absorbance 280nm  6.58

Polar residues  4

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 28699258

Title  Cytotoxic peptides with insulin-releasing activities from skin secretions of the Italian stream frog Rana italica (Ranidae)

Doi 10.1002/psc.3025

Year  2017

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.